Date lodged: 9 November 2016
To ask the Scottish Government what steps it will take to ensure that the Scottish Medicines Consortium adopts a pro-innovation outlook so that cancer patients can benefit from new and promising classes of therapy.
Answered by: Shona Robison 21 November 2016
In recent years, the Scottish Government have made significant reforms and investment to improve access to newly licensed medicines. However, I do think that more can be done to build on the progress made to date which is why I asked Dr Brian Montgomery to conduct an independent review. I have received his report and I am considering his recommendations.
In Scotland, we have a clear and consistent route for new drugs to be appraised through the long standing independent Scottish Medicines Consortium (SMC). There are a number of medicines which have been accepted by the SMC for routine use within the NHS in Scotland for the treatment of cancer.